BOSTON — Over the past 20 years, a variety of new drugs with different mechanisms of action have been approved for the treatment of osteoporosis. However, around the world, treatment of this disease remains low, noted Michael R. McClung, MD, of the Oregon Osteoporosis Center.

In this video from ENDO 2016, Dr McClung discusses his Plenary Session presentation about some of the newer therapies under investigation for treatment osteoporosis.

Continue Reading